ProfoundBio
An oncology biotherapeutics company
Woodinville, United States
8 employees
Series B
Total: $247.00M
Biotechnology, Health and Wellness
General Information
Woodinville, United States
BounceWatch is an independent company data service, not affiliated with ProfoundBio. To contact ProfoundBio, visit profoundbio.com.
Is this your company?
Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.
Get Verified
How does ProfoundBio compare?
A PDF of ProfoundBio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.
This takes a few seconds: we look beyond our own index too.
Meeting ProfoundBio soon?
A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample
Discover More
United States Market
Biotechnology
About ProfoundBio
Business keywords: antibody-based therapeutics, clinical-stage, cancer research, ADC drug candidates, solid tumors, hematological malignancies, proprietary technology, Seattle, cancer treatment, innovative drug development, oncology, targeted therapy, precision medicine
Funding Rounds & Investors (4)
View All| Funding Stage | Amount | Investors | Lead Investors | Date |
|---|---|---|---|---|
| Series B | $112.00M | 1 |
Genmab
|
01 Apr 2024 |
| Series A | $70.00M | 7 |
|
01 Jun 2022 |
| Series A | $55.00M | 7 |
|
01 Jul 2021 |
| Seed | $10.00M | 3 |
|
01 Feb 2021 |
ProfoundBio Alternatives & Competitors
View All Alternatives
Next generation antibody drug conjugates
Disruptive Innovations to Treat Unmet Therapeutic Needs in Oncology
Targeted Therapy Delivered
Mersana Therapeutics
FAQ About ProfoundBio
Source: BounceWatch company record for ProfoundBio, https://bouncewatch.com/company/profoundbio, updated 2 July 2026. When citing, please name BounceWatch and link this page.
